Literature DB >> 15079038

Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.

R Hering1, S Petrovic, E-M Mietz, C Holzmann, D Berg, P Bauer, D Woitalla, T Müller, K Berger, R Krüger, O Riess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15079038     DOI： 10.1212/01.wnl.0000118285.18383.90

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  17 in total

1.  Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.

Authors:  T Franck; R Krueger; D Woitalla; T Müller; S Engelender; O Riess
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

Review 2.  NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors:  Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

3.  Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

Authors:  Francesca Montarolo; Simona Perga; Serena Martire; Désirée Nicole Navone; Alberto Marchet; Daniela Leotta; Antonio Bertolotto
Journal:  Neurotox Res       Date:  2016-05-09       Impact factor: 3.911

4.  Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.

Authors:  Chun-Hyung Kim; Baek-Soo Han; Jisook Moon; Deog-Joong Kim; Joon Shin; Sreekanth Rajan; Quoc Toan Nguyen; Mijin Sohn; Won-Gon Kim; Minjoon Han; Inhye Jeong; Kyoung-Shim Kim; Eun-Hye Lee; Yupeng Tu; Jacqueline L Naffin-Olivos; Chang-Hwan Park; Dagmar Ringe; Ho Sup Yoon; Gregory A Petsko; Kwang-Soo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

5.  Daphnane Diterpenes from Daphne genkwa Activate Nurr1 and Have a Neuroprotective Effect in an Animal Model of Parkinson's Disease.

Authors:  Baek-Soo Han; Kyoung-Shim Kim; Yu Jin Kim; Hoe-Yune Jung; Young-Mi Kang; Kyu-Suk Lee; Mi-Jin Sohn; Chun-Hyung Kim; Kwang-Soo Kim; Won-Gon Kim
Journal:  J Nat Prod       Date:  2016-05-26       Impact factor: 4.050

6.  Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease.

Authors:  Howard J Federoff
Journal:  Neurotox Res       Date:  2009-04-24       Impact factor: 3.911

7.  Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.

Authors:  P M A Sleiman; D G Healy; M M K Muqit; Y X Yang; M Van Der Brug; J L Holton; T Revesz; N P Quinn; K Bhatia; J K J Diss; A J Lees; M R Cookson; D S Latchman; N W Wood
Journal:  Neurosci Lett       Date:  2009-03-11       Impact factor: 3.046

Review 8.  Genetics of parkinsonism.

Authors:  Alistair J Lewthwaite; David J Nicholl
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

9.  Mutation and evolutionary analyses identify NR2E1-candidate-regulatory mutations in humans with severe cortical malformations.

Authors:  R A Kumar; S Leach; R Bonaguro; J Chen; D W Yokom; B S Abrahams; L Seaver; C E Schwartz; W Dobyns; A Brooks-Wilson; E M Simpson
Journal:  Genes Brain Behav       Date:  2006-11-29       Impact factor: 3.449

10.  Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.

Authors:  Sang-Min Oh; Mi-Yoon Chang; Jae-Jin Song; Yong-Hee Rhee; Eun-Hye Joe; Hyun-Seob Lee; Sang-Hoon Yi; Sang-Hun Lee
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.